Equity Overview
Price & Market Data
Price: $27.96
Daily Change: +$0.43 / 1.54%
Range: $27.33 - $27.96
Market Cap: $33,189,357,568
Volume: 3,716
Performance Metrics
1 Week: 4.30%
1 Month: 19.65%
3 Months: 30.95%
6 Months: 34.69%
1 Year: 69.88%
YTD: 26.27%
Company Details
Employees: 6545
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Switzerland
Details
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.